Grow a diversified
global business

Hand holding a line graph

We are reducing risk by broadening and balancing our portfolio, diversifying into new product areas that show potential, while also fully capturing opportunities for our products across all geographic boundaries.

Specifically, we expect to generate future sales growth by strengthening our core pharmaceuticals business and supplementing it with increased investment in growth areas such as vaccines, biopharmaceuticals and consumer healthcare.

We are also seeking to unlock the geographic potential of our businesses, particularly in emerging markets and Japan.

We have made good progress on this priority during 2008, and we believe there remain many opportunities for GSK to diversify further.

Our plansAndrew Witty

  • Drive growth in the pharmaceutical business in our core markets
  • Deliver our ambitious vaccines forecast
  • Fulfil the potential of emerging markets
  • Expand our business in Japan
  • Grow the Consumer Healthcare business

It's important that we generate more growth with less risk.”

Moving forwards

Image of Andrew Witty

CEO Andrew Witty talks about latest progress of GSK’s strategic priorities in this series of videos:

Deliver

Image of researcher

We are transforming R&D.

Simplify

Image of man and cogs graphic

We are changing the way we work.